Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf

Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf

Background<p>Psoriasis is a long-term, immune-mediated inflammatory disorder of the skin, affecting about 2-3% of the global population with rising prevalence rates. Clinical practice has demonstrated that Fuzhenghefuzhiyang formula (FZHFZY), a topical medication applied Chinese herbal formula...

保存先:

書誌詳細
第一著者:	Bin Tang (56654) (author)
その他の著者:	Chen Zhang (66790) (author), Yujie Yang (2327590) (author), Haixin Zhong (18240646) (author), Kexin Yang (9733218) (author), Hao Deng (409186) (author), Jingjie Yu (3549059) (author), Yonggen Chen (17964038) (author), Xiangliang Deng (8499348) (author), Chuanjian Lu (534232) (author), Haiming Chen (355433) (author)
出版事項:	2025
主題:	Genetic Immunology psoriasis FZHFZY transcriptomics metabolomics integrated analysis NLRP3
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Data Sheet 2_Sporoderm-removed ganoderma lucidum spore powder (S-GLSP) alleviates neuroinflammation injury by regulating microglial polarization through inhibition of NLRP3 inflammasome activation.pdf
著者:: Wenli Li (337819)
出版事項: (2025)

Data Sheet 1_Sporoderm-removed ganoderma lucidum spore powder (S-GLSP) alleviates neuroinflammation injury by regulating microglial polarization through inhibition of NLRP3 inflammasome activation.pdf
著者:: Wenli Li (337819)
出版事項: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
著者:: Xuefeng Liang (3838222)
出版事項: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
著者:: Xuefeng Liang (3838222)
出版事項: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
著者:: Xuefeng Liang (3838222)
出版事項: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
著者:: Xuefeng Liang (3838222)
出版事項: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
著者:: Xuefeng Liang (3838222)
出版事項: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
著者:: Xuefeng Liang (3838222)
出版事項: (2025)

Additional file 1 of Combined metabolome and transcriptome profiling provides insights into dynamic molecular control of lemon (Citrus Limon L.) peel development
著者:: Hongming Liu (631933)
出版事項: (2025)

Data Sheet 1_Transcriptome and metabolome analyses revealed the main profiles contributing the mild aroma characteristics of Artemisia stolonifera.docx
著者:: Ye Cao (849948)
出版事項: (2025)

Table 1_Melatonin mitigates cadmium-induced oxidative damage and modulates polysaccharide biosynthesis in Bletilla striata.xlsx
著者:: Deqiong Niu (19691873)
出版事項: (2025)

Data Sheet 1_Melatonin mitigates cadmium-induced oxidative damage and modulates polysaccharide biosynthesis in Bletilla striata.docx
著者:: Deqiong Niu (19691873)
出版事項: (2025)

Supplementary file 1_Metabolic reprogramming in PGPR reveals cross-feeding-driven physiological shifts and metabolic adaptations.docx
著者:: Kamogelo Mmotla (22674650)
出版事項: (2025)

Supplementary file 1_Drug combination discovery assisted by AI and untargeted metabolomics: pamiparib and anlotinib synergistic potentiation for ovarian cancer treatment.docx
著者:: Dong Wang (73290)
出版事項: (2025)

Integrating urinary metabolomics and clinical datasets for multi-cancer detection
著者:: Dongyong Lee (18786694)
出版事項: (2025)

Data Sheet 1_Exploring the stroke burden linked to Kidney dysfunction: trends, predictive insights, and health inequalities.pdf
著者:: Jiahao Tang (12360233)
出版事項: (2025)

Supplementary file 2_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.doc
著者:: Zhen Yang (107412)
出版事項: (2025)

Supplementary file 1_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.pdf
著者:: Zhen Yang (107412)
出版事項: (2025)

Supplementary file 4_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.docx
著者:: Zhen Yang (107412)
出版事項: (2025)

Supplementary file 3_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.docx
著者:: Zhen Yang (107412)
出版事項: (2025)

Quantitative Proteomics Links Mitochondrial Dysfunction to Metabolic Changes and Epithelial Differentiation Defects in Hyperoxia-Exposed Neonatal Airway Cells
著者:: Abhrajit Ganguly (21540245)
出版事項: (2025)

Table S2 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
著者:: Qiangsheng Hu (15400215)
出版事項: (2025)

Table S3 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
著者:: Qiangsheng Hu (15400215)
出版事項: (2025)

Supplementary Table S1 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
著者:: Phyllis S.Y. Chong (17141520)
出版事項: (2025)

Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
著者:: Phyllis S.Y. Chong (17141520)
出版事項: (2025)

Supplementary Figure S1 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Supplementary Figure S2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Supplementary Figure S3 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Supplementary Figure S4 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Supplementary Figure S5 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Supplementary Figure S6 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Supplementary Figure S7 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Supplementary Figure S8 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Supplementary Table 2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Supplementary Table 3 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Supplementary Table 4 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Supplementary Table 5 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
著者:: Andrew W. Hahn (15024693)
出版事項: (2025)

Figure 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
著者:: James R. Larkin (14936324)
出版事項: (2025)

Figure 2 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
著者:: James R. Larkin (14936324)
出版事項: (2025)

Figure 3 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
著者:: James R. Larkin (14936324)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_qos6ckc3slt1o8ikff65865k48